1. Executive Opening: Why KPIs Alone Are Not Enough In sterile pharmaceutical manufacturing, outcomes are unforgiving. A single lapse in aseptic discipline can compromise patient safety, trigger regulatory observations, and erode brand trust. Yet, many organizations still rely heavily on Key Performance Indicators (KPIs)—batch rejection rates, OOS trends, or release cycle times—to judge success. The …
Category Archives: QMM
💉 Injectable Site – Operational Excellence KPI Dashboard
1. 🧪 Quality & Compliance (Critical for Injectable Sites) KPIDefinitionTargetFrequencyOwnerBatch Rejection Rate% of batches rejected vs total manufactured≤ 0.5%MonthlyQA HeadOOS (Out of Specification)No. of OOS per 1000 tests↓ TrendWeeklyQC HeadOOS Closure TATAvg. days to close OOS≤ 30 daysWeeklyQARight First Time (RFT)% batches released without deviation≥ 98%MonthlyProductionSterility Failure RateFailures in sterility tests0MonthlyMicrobiologyAudit ObservationsNo. of critical/major findings0 …
Continue reading “💉 Injectable Site – Operational Excellence KPI Dashboard”
USFDA Inspection Readiness Through Operational Excellence
Building a Culture of Continuous Compliance and Excellence In the global pharmaceutical industry, few moments test an organization’s maturity like an inspection by the U.S. Food and Drug Administration (USFDA). Yet, the most successful organizations no longer view inspections as high-pressure events—they see them as validation of a system that is always in control. “Quality …
Continue reading “USFDA Inspection Readiness Through Operational Excellence”
Enhancing Quality Management Maturity in Pharma
🏭 Quality Management Maturity (QMM): Building a Future-Ready Pharmaceutical Manufacturing Site In today’s highly regulated pharmaceutical environment, compliance alone is no longer enough. Global regulators like the USFDA are increasingly focusing on Quality Management Maturity (QMM)—a framework that evaluates how well a manufacturing site goes beyond compliance to achieve sustainable, proactive, and high-performing quality systems. …
Continue reading “Enhancing Quality Management Maturity in Pharma”